Chemoinformaics analysis of Gamma-L-Glutamyl-S-(1-Propenyl)-Cysteine-Sulfoxide
Molecular Weight | 306.34 | nRot | 9 |
Heavy Atom Molecular Weight | 288.196 | nRig | 4 |
Exact Molecular Weight | 306.089 | nRing | 0 |
Solubility: LogS | -1.272 | nHRing | 0 |
Solubility: LogP | -3.128 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 40.2843 |
nHD | 4 | BPOL | 25.2197 |
QED | 0.4 |
Synth | 4.374 |
Natural Product Likeliness | 0.549 |
NR-PPAR-gamma | 0.106 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.648 |
HIA | 0.069 |
CACO-2 | -6.394 |
MDCK | 0.00353283 |
BBB | 0.436 |
PPB | 0.0835411 |
VDSS | 0.34 |
FU | 0.803143 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.03 |
CYP2c19-sub | 0.037 |
CYP2c9-inh | 0.091 |
CYP2c9-sub | 0.704 |
CYP2d6-inh | 0.021 |
CYP2d6-sub | 0.12 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.002 |
CL | 2.36 |
T12 | 0.821 |
hERG | 0.007 |
Ames | 0.108 |
ROA | 0.013 |
SkinSen | 0.261 |
Carcinogencity | 0.145 |
EI | 0.042 |
Respiratory | 0.13 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.640551 |